coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Leigh PCN, Wigan (LAD) · Health Inequalities Profile

    PCN U70230 · NHS Greater Manchester Integrated Care Board · 10 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    59,801

    Registered population

    61.1% aged 18–64

    18.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    52.7%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~30,218

    Core20 residents (est.)

    Resident basis; registered basis ~32,660 · see page 3

    9,589

    Hypertension register

    +8.08% in 3 yrs · England +5.60%

    595

    SMI register

    16.6% of Wigan (LAD)'s

    1,759

    COPD register

    Reviews +0.07% in 3 yrs

    Forecast to 2030

    11,459

    Hypertension patients, 2030

    +1,870 on today

    72.6%

    QRISK ≥20% on statins, 2030

    +2.95pp over 3 yrs

    4.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    15.9%
    Hypertension register trails the Wigan borough rate.

    Recorded hypertension prevalence is 15.9% versus 18.0% in Wigan, an unadjusted benchmark gap of 1,200 patients that could reflect unverified under-detection.

    79.4%
    Age-five pre-school boosters fall below target.

    At age 5, 4-in-1 booster coverage is 79.4% (15.6 pp below the 95.0% target) and MMR dose 2 is 84.4% in Q1 2025/26.

    75.1%
    Registered hypertension and diabetes control beats England.

    Hypertension treatment to target reaches 75.1% (England 70.3%) and non-frail diabetes HbA1c control reaches 60.7% (England 57.4%) among registered patients.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older patients make up 18.1% of registrations while projected population growth is 1.2%

    LEIGH PCN has 59,801 registered patients. Patients aged 65+ represent 18.1% (10,795), compared with 18.8% in Wigan (LAD), 14.9% in NHS Greater Manchester Integrated Care Board, and 17.9% in England. Those aged 0–17 comprise 20.8% (12,442), against 20.0% in Wigan (LAD), 21.8% in the ICB, and 19.6% in England. Projected list growth to 2030 is 1.2% under an unverified methodology (Wigan LAD 1.1%, ICB 1.6%, England 2.3%). Census resident estimates show 0.1% Gypsy or Irish Traveller and 0.2% Roma. Registered patient counts and Census populations use distinct bases.

    Age profile

    0–1720.8%
    18–6461.1%
    65+18.1%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Wigan (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wigan LA)2,7062,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wigan LA)1,2431,0219552024/25
    Falls deaths, all ages, per 100,000 (Wigan LA)12.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients comprise 52.7% of the list, with all ten practices exceeding England

    In Leigh PCN, 52.7% of registered patients live in Core20 areas, above Wigan (29.4%), the ICB (40.7%) and England (21.0%). The weighted practice rate of 54.6% shows a 1.94 percentage point discrepancy. Concentration ranges from 41.4% at Westleigh Medical Practice to 67.6% at Leigh Family Practice. In volume, Leigh Family Practice (6,759 estimated patients) and Lilford & Pennington Park Surgery (4,183) hold the largest caseloads. Targeting preventive checks by patient volume may help reach the largest Core20 populations.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Leigh67.6% · 6,759 patients
    Old Henry Street63.2% · 3,776 patients
    Avenue60.4% · 2,921 patients
    Lilford &60.0% · 4,183 patients
    Foxleigh Family59.8% · 1,381 patients
    Premier Health50.2% · 2,231 patients
    Brookmill48.1% · 4,100 patients
    Grasmere44.9% · 3,412 patients
    Leigh Sports43.7% · 2,069 patients
    Westleigh Medical41.4% · 1,828 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    595

    SMI register

    0.99% recorded prevalence

    430

    Learning disability register

    0.71% recorded prevalence

    9

    Care homes, 524 beds

    In the PCN catchment

    10.1%

    Provide unpaid care

    Wigan (LAD), Census 2021

    The PCN records 595 severe mental illness patients (1.0%) and 430 on the learning disability register (0.7%, above England's 0.6%), representing 19% of the borough register. Catchment assets include 9 care homes with 524 beds. Wigan recorded 11 rough sleepers in 2025; borough counts cannot be extrapolated to PCN lists.

    Severe mental illness: physical health checks

    SMI prevalence is 1.0% (England 1.0%, Wigan (LAD) 1.0%). Annual blood pressure checks reached 86.2% (England 83.4%) and BMI recording reached 84.8% (England 82.1%). Captured check elements are separate and do not confirm complete physical health checks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,589

    Hypertension register

    +8.08%

    Register growth, 3 yrs

    Wigan (LAD) +10.59% · England +5.60%

    +2.52pp

    BP control, under 80

    ≤140/90 · +4.20pp aged 80+

    +1,870

    More patients by 2030

    Forecast 11,459 (18.54%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 15.9% (9,589 patients), exceeding England (15.2%) and NHS Greater Manchester Integrated Care Board (14.4%) but below Wigan (LAD) (18.0%). Between 2023 and 2025, recorded prevalence changed +8.1% (England +5.6%, Wigan (LAD) +10.6%). Treatment processes show 91.5% had a recent blood pressure check and 75.1% are treated to target, above England (70.3%) and the ICB (71.4%). Against borough prevalence, an unadjusted benchmark comparison indicates a gap of 1,200 patients across an unadjusted range of -481 to +1,200. Lower recorded prevalence than the borough benchmark may reflect population age structure or case finding differences that clinical audit could test.

    Lipids and statins

    For primary prevention, 66.3% of patients with QRISK ≥ 20% receive lipid-lowering therapy, above England (63.6%) and Wigan (LAD) (64.0%) but below NHS Greater Manchester Integrated Care Board (67.0%). From 2023 to 2025, therapy changed +4.7% (England +6.2%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026112,525£2.20£1.94£1.86£247,555
    Cardiovascular (all), 2025147,633£4.25£3.15£3.33£627,440

    The PCN prescribed 112,525 lipid-regulating drug items in 2026, representing £247,555 annual spend. Cost per item was £2.20, exceeding England (£1.86) and NHS Greater Manchester Integrated Care Board (£1.94). The PCN spent £38,258 more than at England's unit cost and £29,256 more than at the ICB's.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +9.63%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.82%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.9% (1,759 patients), above Wigan (LAD) (2.6%), NHS Greater Manchester Integrated Care Board (2.3%) and England (1.9%), changing +16.8% between 2023 and 2025 (England +2.6%). The COPD review rate was 76.3% (changing +0.1% versus England +2.8%). Asthma prevalence is 7.4% (4,211 patients), above England (6.6%), with a 65.5% review rate leaving about 1,500 unreviewed patients. Asthma prescribing for ages 5–19 reached 2,431 items per 1,000 (England 1,488), while second-hand smoke status recording for ages 6–19 was 74.8% (England 78.8%).

    Cancer register and children's immunisation

    The cancer register records 2,095 patients (3.5% prevalence, England 3.8%). In Q1 2025/26, 6-in-1 coverage at 24 months was 95.2%. At age 5, MMR dose 1 coverage was 94.4%, while dose 2 was 84.4%, a 10 pp difference between doses in the same cohort. Pre-school 4-in-1 booster coverage was 79.4%, below the 95.0% target by 15.6 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.2%

    England 91.0%

    6-in-1 complete primary course at 24 months95.2%

    England 92.2%

    MMR dose 1 at 24 months93.5%

    England 88.3%

    MMR dose 2 at age 584.4%

    England 82.8%

    4-in-1 pre-school booster at age 579.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of cancers with a known stage (6,491 of 11,679) across NHS Greater Manchester ICB were diagnosed at stage 1 or 2, comparable to England (55.3%) but below the 75.0% national ambition by 19.4 pp. Staged cancers represented 70.8% of 16,492 registered cases, above England's 67.0%. Between 2013 and 2022, the ICB early-stage share rose +3.1 pp from 52.4%, yet reaching 75.0% requires about 2,270 additional early diagnoses annually. Early detection varies by site, from 82.5% in breast to 40.4% in lung and 22.4% in oesophagus. Staging reflects regional pathways, not PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Pathways within standard (%)Wrightington, Wigan and LeighBoltonManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)82.8080.4880.0679.5379.32
    31-day treatment (96%)89.0496.5092.5496.4992.50
    62-day referral to treatment (85%)76.7869.6672.8575.7371.16
    Diagnostic waits over 6 weeks (%)Wrightington, Wigan and LeighBoltonManchesterEngland
    MRI0.492.0511.6821.40
    CT7.7819.4014.669.92
    Echocardiography24.373.484.9128.48
    Colonoscopy6.101.334.5130.83
    Gastroscopy12.542.0629.3529.02
    All 15 DM01 tests14.3615.788.9823.14
    Community services activityWigan residentsGreater Manchester ICB
    Care contacts48,150573,310
    Referrals13,75094,470
    Patients with a contact18,695183,535

    Community services (residents of Wigan), Jun 2026 (provisional). In provisional community services returns for June 2026, adults aged 65 and over accounted for 58.5% of all community contacts among borough residents (28,190 of 48,150 contacts). Older residents account for the majority of community activity across the borough, though these figures describe local authority residents rather than PCN-level activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, overall QOF achievement was 90.4% at Leigh Family Practice, while Westleigh Medical Practice achieved 98.2% (England: 92.5%). For QOF vaccination and immunisation-domain achievement, Leigh Family Practice achieved 15.6% (England: 55.2%), whereas Westleigh Medical Practice achieved 83.8%, reflecting a range of 68.2 pp. This wide variation may indicate preventative care disparities, which audits of individual uptake could test.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Premier Health12450.286.2%64.9%91.7%
    The Avenue Surgery12160.488.4%66.9%90.5%
    Grasmere Surgery11544.987.9%85.2%90.4%
    Foxleigh Family10559.890.3%79.8%85.1%
    Old Henry Street10363.276.3%84.0%81.2%
    Lilford &11360.069.1%77.1%76.8%
    Brookmill11348.167.2%78.0%75.9%
    Leigh Sports10043.756.7%82.1%74.6%
    Leigh10267.666.1%78.9%70.1%
    Westleigh Medical10741.451.1%68.2%61.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWigan (LAD)AssetPCNWigan (LAD)
    Care homes (catchment)9 (524 beds)n/aSchools (catchment)38n/a
    Children's centres420Places of worship29164
    Libraries110Primary schools (LA maintained)1568
    Primary academies421Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Opportunistic hypertension case-finding audit

    Recorded hypertension prevalence is 15.9% (9,589 patients), below Wigan (LAD) at 18.0% (+1,200 patients unadjusted; range -481 against England's 15.2% to +1,200). For discussion, practices could run electronic searches for patients with repeated raised blood pressure readings without a hypertension code and offer opportunistic checks. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured asthma review and recall

    On the 4,211-patient asthma register (7.4% prevalence), 65.5% had a review in 12 months (ICB 66.2%, England 65.7%), leaving 1,451 (about 1,500) unreviewed. For discussion, the PCN could run structured recall using a single review template, checking inhaler prescribing and second-hand smoke exposure during after-school slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Pre-school booster and MMR2 recall

    In Q1 2025/26 (cohort 160), age-5 MMR2 was 84.4% (10.6 pp below the 95.0% target; 10 pp below MMR1 at 94.4%) and 4-in-1 was 79.4% (15.6 pp below 95.0%, England 80.9%). Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 clinical outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Hypertension case finding review (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Urgent cancer referral safety netting (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Option 1 · Opportunistic hypertension case-finding audit (p12)Hypertension register · Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured asthma review and recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Pre-school booster and MMR2 recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15